What is King Pharmaceuticals's premiums written, net?

King Pharmaceuticals (KG) reported premiums written, net of $2.65M in Q1 2026.

King Pharmaceuticals KG Premiums Written, Net

Premiums Written, Net at other companies

SiriusPointSPNT

——

W.R. BerkleyWRB

——

Universal Insurance HoldingsUVE

——

Greenlight Capital RE, Ltd.GLRE

——

Segments

By segment

See full

Legacy Reinsurance$2.65M—

AmTrust Legacy Segment$1.88M—

Diversified Legacy Segment$775K—

By geography

See full

Other (predominantly Europe)$6.29M—

North America-$80K—

Other financials

Income statement

See full

Revenue$10.2M+1,112%

Net income-$7.4M-1,786%

EPS (diluted)-$0.96-586%

Balance sheet

See full

Cash & equivalents$62.2M+1,724%

Total debt$176.7M—

Total equity$121.4M+2,773%

Total assets$964.2M—

Cash flow

See full

Operating cash flow-$15.1M-1,628%

Valuation

See full

Market cap$70.42M-71.3%

Enterprise value$184.93M-52.3%

P/E1.2×—

P/S1.6×-27.7×

Profitability

See full

Net margin131.5%—

Returns & leverage

See full

Return on equity90.8%—

Debt / equity1.5×—

Where this comes from

Reported directly by King Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:PremiumsWrittenNet.

The official record: King Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about King Pharmaceuticals's premiums written, net.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is King Pharmaceuticals's premiums written, net?: King Pharmaceuticals (KG) reported premiums written, net of $2.65M in Q1 2026.